Merck & Co.: Clinical Trials & Research Profile

Biopharma Industry (Rahway, NJ) · Primary Focus: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeConsolidated Trial Sponsor
Institutional Sector & LocationBiopharma Industry (Rahway, NJ)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies201 active (101 recruiting now)
Total Tracked Studies (2018 to 2026)439 (270 with California sites)
Completed vs Early-Stopped Studies195 completed / 43 stopped (9.8% stop rate)
Median Closed Enrollment302 participants
FDA Drugs@FDA Original Approvals183 all-time (15 from 2018 to 2026)
Physical Hospital Site Disclosure99.9% named hospital slots

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Merck & Co. across sibling Meru public-data platforms.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk